More on BMY

- Summary
- Chart
- Profile
- Historical


- Earnings
- Ratings
- Holders
- Dividends


Income Statement
Balance Sheet
Cash Flow Statement


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

BMY Balance Sheet

Click line-items for a historical chart and %
Current Assets:
Cash and cash equivalents 3.59B
Marketable securities 939M
Receivables 3.36B
Inventories 1.5B
Deferred income taxes 1.7B
Prepaid expenses and other
Total Current Assets 18.92B
Property, plant and equipment 4.58B
Goodwill 7.1B
Other intangible assets 2.32B
Deferred income taxes 508M
Marketable securities 3.75B
Other assets 1.43B
Total Assets 38.59B
Current Liabilities:
Short-term borrowings
Accounts payable 2.56B
Accrued expenses 2.15B
Deferred income 756M
Accrued rebates and returns 889M
U.S. and foreign income taxes payable 160M
Dividends payable 634M
Total Current Liabilities 12.44B
Pension, postretirement, and postemployment liabilities 718M
Deferred income 769M
U.S. and foreign income taxes payable 750M
Other liabilities 625M
Long-term debt 7.98B
Total Liabilities 23.36B
Commitments and contingencies (Note 14) 0
Bristol-Myers Squibb Company Shareholders' Equity:
Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 5,268 in 2011 and 5,269 in 2010, liquidation value of $50 per share 0
Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2011 and 2010 221M
Capital in excess of par value of stock 1.92B
Accumulated other comprehensive loss -2.14B
Retained earnings 32.95B
Less cost of treasury stock - 500 million common shares in 2011 and 501 million in 2010 -17.8B
Total Bristol-Myers Squibb Company Shareholders' Equity 15.15B
Noncontrolling interest 82M
Total Equity 15.24B
Total Liabilities and Equity 38.59B